ORIC Pharmaceuticals
(NASDAQ) ORIC
ORIC Pharmaceuticals Financials at a Glance
Market Cap
$1.24B
Revenue (TTM)
$0.00
Net Income (TTM)
$129.47M
EPS (TTM)
$-1.51
P/E Ratio
-8.17
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$12.35
Volume
57,820
Open
$11.51
Price
$12.35
Volume
57,820
Open
$11.51
Previous Close
$12.35
Daily Range
$11.51 - $12.60
52-Week Range
$3.90 - $14.93
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$12.35
Volume
57,820
Open
$11.51
Previous Close
$12.35
Daily Range
$11.51 - $12.60
52-Week Range
$3.90 - $14.93
ORIC News
ORIC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ORIC Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
104
CEO
Jacob M. Chacko, MD, MBA
Website
www.oricpharma.comHeadquarters
South San Francisco, CA 94080, US
ORIC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-41%
Return on Capital
-37%
Return on Assets
-32%
Earnings Yield
-12.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.24B
Shares Outstanding
100.36M
Volume
57.82K
Short Interest
0.00%
Avg. Volume
1.64M
Financials (TTM)
Gross Profit
$1.22M
Operating Income
$143.00M
EBITDA
$128.25M
Operating Cash Flow
$113.37M
Capital Expenditure
$712.00K
Free Cash Flow
$114.08M
Cash & ST Invst.
$281.49M
Total Debt
$11.55M
ORIC Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$320.00K
-5.3%
Gross Margin
0.00%
N/A
Market Cap
$1.24B
N/A
Market Cap/Employee
$10.18M
N/A
Employees
122
N/A
Net Income
$30.50M
+16.0%
EBITDA
$30.18M
+16.2%
Quarterly Fundamentals
Net Cash
$269.94M
+6.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$8.22M
N/A
Short Term Debt
$3.33M
+4.6%
Return on Assets
-31.50%
N/A
Return on Invested Capital
-36.61%
N/A
Free Cash Flow
$22.87M
+19.1%
Operating Cash Flow
$22.48M
+19.9%